2-trifluoromethoxydibenz [b,e][1,4] diazepine and 2-trifluoromethoxydibenz [b,f][1,4]-oxazepine derivatives.
D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D003984:Dibenzazepines / Q000138:chemical synthesis / Q000627:therapeutic use; D003989:Dibenzoxazepines / Q000138:chemical synthesis / Q000627:therapeutic use; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D012640:Seizures / Q000517:prevention & control
D003984:Dibenzazepines; D003989:Dibenzoxazepines